Could a bone drug help men with enlarged prostate?
NCT ID NCT06944145
First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 35 times
Summary
This study tests whether adding raloxifene (a drug used for bone health) to finasteride (a standard BPH drug) works better than finasteride alone for men with an enlarged prostate. About 242 adults will take either the combo or finasteride plus a placebo for 12 months. The main goal is to see if symptoms improve by at least 3 points on a standard symptom scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACK SYMPTOMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
finasteride and raloxifene
What this could lead to
If successful, this combination could offer a new treatment option for men with BPH who don't respond to finasteride alone.
What could go wrong
This is a mid-stage trial with 242 participants, so results may not apply to everyone. Raloxifene also carries a risk of blood clots, which limits its use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.